Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis

Cancer Commun (Lond). 2023 May;43(5):620-624. doi: 10.1002/cac2.12409. Epub 2023 Feb 10.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems*
  • DNA
  • Gene Editing*
  • Humans

Substances

  • DNA